These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37776114)

  • 1. Prevalence and patterns of catastrophic spending for antidiabetic medication in 2020.
    Devine JW; Lim D; Lugo A; Farley JF
    J Manag Care Spec Pharm; 2023 Oct; 29(10):1158-1164. PubMed ID: 37776114
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016.
    Chen EM; Kombo N; Teng CC; Mruthyunjaya P; Nwanyanwu K; Parikh R
    Ophthalmology; 2020 Oct; 127(10):1292-1302. PubMed ID: 32359935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
    Daniel GW; Malone DC
    J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription drug spending and hospital use among Medicare beneficiaries with heart failure.
    McGee BT; Higgins MK; Phillips V; Butler J
    Res Social Adm Pharm; 2020 Oct; 16(10):1452-1458. PubMed ID: 31953113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Out-of-Pocket Spending and Premium Contributions After Implementation of the Affordable Care Act.
    Goldman AL; Woolhandler S; Himmelstein DU; Bor DH; McCormick D
    JAMA Intern Med; 2018 Mar; 178(3):347-355. PubMed ID: 29356828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catastrophic Spending On Insulin In The United States, 2017-18.
    Bakkila BF; Basu S; Lipska KJ
    Health Aff (Millwood); 2022 Jul; 41(7):1053-1060. PubMed ID: 35787081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.
    Yeung K; Dusetzina SB; Basu A
    JAMA Netw Open; 2021 Jun; 4(6):e2113393. PubMed ID: 34125219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Medicare Part D on Prescription Drug Spending and Health Care Use: 6 Years of Follow-up, 2007-2012.
    Park T; Jung J
    J Manag Care Spec Pharm; 2017 Jan; 23(1):5-12. PubMed ID: 28025927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the US Affordable Care Act With Out-of-Pocket Spending and Catastrophic Health Expenditures Among Adult Patients With Traumatic Injury.
    Liu C; Tsugawa Y; Weiser TG; Scott JW; Spain DA; Maggard-Gibbons M
    JAMA Netw Open; 2020 Feb; 3(2):e200157. PubMed ID: 32108892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the Concentration and Distribution of Health Care Expenditures in the US, 2001-2018.
    Holle M; Wolff T; Herant M
    JAMA Netw Open; 2021 Sep; 4(9):e2125179. PubMed ID: 34519767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
    Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
    J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why the increase? Examining the rise in prescription medication expenditures in the United States between 2011 and 2020.
    Chi W; Song J; Yazdanfard S; Daggolu J; Varisco TJ
    Res Social Adm Pharm; 2024 Apr; 20(4):432-442. PubMed ID: 38302297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
    Stuart B; Shaffer TJ; Simoni-Wastila LJ; Zuckerman IH; Quinn CC
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease.
    Hennessy D; Sanmartin C; Ronksley P; Weaver R; Campbell D; Manns B; Tonelli M; Hemmelgarn B
    Health Rep; 2016 Jun; 27(6):3-8. PubMed ID: 27305075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress on impoverishing health spending in 122 countries: a retrospective observational study.
    Wagstaff A; Flores G; Smitz MF; Hsu J; Chepynoga K; Eozenou P
    Lancet Glob Health; 2018 Feb; 6(2):e180-e192. PubMed ID: 29248366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
    Pauly NJ; Talbert JC; Brown J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does increased adherence to medications change health care financial burdens for adults with diabetes?
    Miller GE; Sarpong EM; Hill SC
    J Diabetes; 2015 Nov; 7(6):872-80. PubMed ID: 25817601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of Insurance Churn and Catastrophic Health Expenditures With Implementation of the Affordable Care Act Among Nonelderly Patients With Cancer in the United States.
    Albright BB; Chino F; Chino JP; Havrilesky LJ; Aviki EM; Moss HA
    JAMA Netw Open; 2021 Sep; 4(9):e2124280. PubMed ID: 34495338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of catastrophic out-of-pocket medical expenditure among older adults in the United States and South Korea: what affects the apparent difference?
    Kim N; Jacobson M
    BMC Health Serv Res; 2022 Sep; 22(1):1202. PubMed ID: 36163016
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.